CP
GILD icon

Canopy Partners’s Gilead Sciences GILD Stock Holding History

Canopy Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Sell
3,382
-375
-10% -$49.4K 0.13% 142
2026
Q1 		$524K Buy
3,757
+302
+9% +$42.3K 0.18% 106
2025
Q4 		$424K Buy
3,455
+177
+5% +$21.5K 0.14% 123
2025
Q3 		$364K Sell
3,278
-225
-6% -$25.6K 0.12% 140
2025
Q2 		$388K Hold
3,503
– – 0.14% 120
2025
Q1 		$393K Sell
3,503
-920
-21% -$94.9K 0.15% 116
2024
Q4 		$409K Buy
4,423
+43
+1% +$3.87K 0.16% 112
2024
Q3 		$367K Sell
4,380
-115
-3% -$8.78K 0.16% 122
2024
Q2 		$308K Buy
4,495
+435
+11% +$29K 0.14% 130
2024
Q1 		$297K Buy
4,060
+393
+11% +$30.2K 0.15% 132
2023
Q4 		$297K Buy
+3,667
New +$285K 0.18% 111

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Canopy Partners's GILD Position: Q2 2026 in Review

Canopy Partners reduced its Gilead Sciences (GILD) stake by 10% in Q2 2026, selling an estimated $49.4K and leaving 3,382 shares worth $427K. The position accounts for 0.13% of the portfolio, ranked #142.

Canopy Partners first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $524K in Q1 2026. 682 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Canopy Partners held 3,382 shares of Gilead Sciences worth $427K as of Q2 2026.
  • Canopy Partners sold 375 Gilead Sciences shares in Q2 2026, an estimated $49.4K.
  • Gilead Sciences made up 0.13% of Canopy Partners's portfolio in Q2 2026, its #142 holding.
  • Canopy Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Canopy Partners's Gilead Sciences position peaked at $524K in Q1 2026.
  • 682 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.